397 related articles for article (PubMed ID: 24596175)
1. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.
van der Laan TP; Plaat BE; van der Laan BF; Halmos GB
Head Neck; 2015 May; 37(5):707-15. PubMed ID: 24596175
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine neoplasms of the larynx: an overview.
Ferlito A; Silver CE; Bradford CR; Rinaldo A
Head Neck; 2009 Dec; 31(12):1634-46. PubMed ID: 19536850
[TBL] [Abstract][Full Text] [Related]
3. High-Grade Neuroendocrine Carcinoma of the Larynx: The Mayo Clinic Experience.
Deep NL; Ekbom DC; Hinni ML; Zarka MA; Patel SH
Ann Otol Rhinol Laryngol; 2016 Jun; 125(6):464-9. PubMed ID: 26611246
[TBL] [Abstract][Full Text] [Related]
4. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor.
Gillenwater A; Lewin J; Roberts D; El-Naggar A
Laryngoscope; 2005 Jul; 115(7):1191-5. PubMed ID: 15995505
[TBL] [Abstract][Full Text] [Related]
5. Carcinoid tumor of the larynx: clinical analysis of 33 cases in Japan.
Ebihara Y; Watanabe K; Fujishiro Y; Nakao K; Yoshimoto S; Kawabata K; Asakage T
Acta Otolaryngol Suppl; 2007 Dec; (559):145-50. PubMed ID: 18340586
[TBL] [Abstract][Full Text] [Related]
6. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
7. Small cell neuroendocrine carcinoma of larynx: case series and literature review.
Iqbal MS; Paleri V; Moor J; Dobrowsky W; Kelly C; Kovarik J
J Laryngol Otol; 2015 Sep; 129(9):910-5. PubMed ID: 26173932
[TBL] [Abstract][Full Text] [Related]
8. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of laryngeal neuroendocrine carcinoma].
Niu YY; Chen XM; Gao ZQ
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1405-7. PubMed ID: 21756813
[TBL] [Abstract][Full Text] [Related]
10. Laryngeal Neuroendocrine Carcinomas: A Retrospective Study of 14 Cases.
Zhu Y; Gao L; Meng Y; Diao W; Zhu X; Li G; Gao Z; Chen X
Biomed Res Int; 2015; 2015():832194. PubMed ID: 26258144
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic study of 9 patients with neuroendocrine carcinoma of the larynx].
Lü D; Yang H; Zhao S; Yang L; Liu SX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Dec; 47(12):1017-20. PubMed ID: 23328043
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases.
Bussu F; Miccichè F; Rigante M; Dinapoli N; Parrilla C; Bonomo P; Cadoni G; Mantini G; Galli J; Rufini V; Almadori G; Valentini V; Paludetti G
Head Neck; 2012 Apr; 34(4):573-9. PubMed ID: 21692130
[TBL] [Abstract][Full Text] [Related]
13. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
14. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
15. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
[TBL] [Abstract][Full Text] [Related]
16. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
17. Treatment, comorbidity and survival in stage III laryngeal cancer.
Connor KL; Pattle S; Kerr GR; Junor E
Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
[TBL] [Abstract][Full Text] [Related]
18. How phenotype guides management of the neuroendocrine carcinomas of the larynx.
López F; Hunt JL; Nixon IJ; Rinaldo A; Williams MD; Cardesa A; Ferlito A
J Laryngol Otol; 2018 Jul; 132(7):568-574. PubMed ID: 29909787
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of neuroendocrine carcinoma of the larynx].
Chen L; Zhang M; Li C; Tao L; Wang SY; Zhou L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Dec; 31(23):1797-1799. PubMed ID: 29798389
[No Abstract] [Full Text] [Related]
20. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
Basheeth N; O'Leary G; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
